Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT00834535
Status:
COMPLETED
Last Update Posted:
2024-08-20
First Post:
2009-01-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Cefdinir Capsules 300 mg, Non-fasting
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R04-1123
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None